ZA07 (Divalproex Sodium Delayed-Release 250 mg)

Pill imprint ZA07 has been identified as Divalproex sodium delayed-release 250 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for ZA07 (Divalproex Sodium Delayed-Release 250 mg)

Divalproex sodium delayed-release 250 mg ZA07
Divalproex sodium delayed-release
Imprint:
ZA07
Strength:
250 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0032
Inactive Ingredients:
hypromelloses
magnesium stearate
methacrylic acid
polyethylene glycol
silicon dioxide
triethyl citrate
sodium starch glycolate type A potato
povidone
magnesium silicate
microcrystalline cellulose
corn starch

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)